Improving human health in the clinic: Human nanomedicine

Title : Improving human health in the clinic: Human nanomedicine

Abstract:

Nanomaterials have been widely tested in vitro and in small order animal studies for decades. Results have shown greater tissue growth, decreased bacteria growth, and inhibited inflammation. However, few studies exist examining human tissue response to nanomaterials. This presentation presents a cohort study of nano implants inserted into humans. In particular, one study includes the implantation of nanotextured spinal implants into over 14,000 patients over the past 5 years. Results demonstrated no cases of infections or other implant failures which is significantly better than statistics on conventional spinal implants which have up to 20% failure rates. This study will further explain that nano implants mimic the natural nano texture of bone itself and possess surface energy that can competitively increase the adsorption of proteins known to promote osteoblast (bone forming cells) functions, decrease bacteria functions, and limit inflammatory cell functions. Further, this invited presentation will highlight the role that environmentally friendly catalysts are playing in fabricating improved nanoparticles for medical applications. As such, this presentation will cover the few human clinical studies on nano implants showing improved human health.

Audience take away points:

•    Why nanomaterials improve tissue growth and decrease infection.
•    How nanomaterials improve tissue growth and decrease infection. 
•    Real human clinical data using nanomaterials to improve human health.

Biography:

Thomas J. Webster’s (H index: 114; Google Scholar) degrees are in chemical engineering from the University of Pittsburgh (B.S., 1995; USA) and in biomedical engineering from RPI (Ph.D., 2000; USA). He has served as a professor at Purdue (2000-2005), Brown (2005-2012), and Northeastern (2012-2021; serving as Chemical Engineering Department Chair from 2012 - 2019) Universities and has formed over a dozen companies who have numerous FDA approved medical products currently improving human health.  He is currently helping those companies and serves as a professor at Hebei University of Technology, Saveetha University, Vellore Institute of Technology, UFPI, and others.  Dr. Webster has numerous awards including: 2020, World Top 2% Scientist by Citations (PLOS); 2020, SCOPUS Highly Cited Research (Top 1% Materials Science and Mixed Fields); 2021, Clarivate Top 0.1% Most Influential Researchers (Pharmacology and Toxicology); 2022, Best Materials Science Scientist by Citations (Research.com); and is a fellow of over 8 societies.  Prof. Webster has over 1,350 publications to his credit with over 53,000 citations. He is a current nominee for the Nobel Prize in Chemistry (2023).